ArticleCureus2026
Integrating a Smart Sensor Chip and AI Predictive Analytics Into the Sehhaty App to Enhance Diabetes Management in Saudi Arabia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes is a major public health challenge in the Kingdom of Saudi Arabia. A substantial proportion of adults are affected, placing significant pressure on the healthcare system. Although digital health initiatives have expanded in recent years, patients continue to encounter barriers to adopting mobile health (mHealth) technologies, including technical limitations, usability concerns, and privacy issues. This article proposes a comprehensive digital health solution for diabetes management that enhances the national health application Sehhaty by integrating two complementary technologies: a smart sensor chip (SSC) for continuous physiological monitoring and AI-based predictive analytics (AIPA) for forecasting glycemic trends. The aim is to strengthen proactive and personalized diabetes care. An Agile development framework consisting of two sprints is proposed. The first sprint integrates a wearable SSC into the Sehhaty ecosystem to transmit real-time glucose and vital sign data through secure wireless communication. The second sprint develops AIPA using machine-learning models to analyze data patterns and predict glycemic fluctuations. System requirements were identified through stakeholder engagement, and the architecture includes a secure cloud backend, structured data flow, and user-centered interface design. The integration of SSC and AIPA into Sehhaty could enhance diabetes management by enabling continuous monitoring, personalized alerts, and earlier intervention. The system design prioritizes reliability, user-centered usability, and data privacy safeguards to address common barriers to digital health adoption. Consideration of perceived usefulness, ease of use, trust, and accessibility informed the development strategy. The proposed SSC-AIPA framework has the potential to transform Sehhaty into an advanced diabetes management platform that supports early detection, predictive insights, and individualized care. Future work will include prototyping, usability evaluation, and clinical validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.